RxDoctor Payments Data

Jillian Walsh, MD

Vascular Surgery · Pennington, NJNPI 1508352048

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Endologix LLC at 33.7% of the total. That places this record below the midpoint for vascular surgery clinicians in NJ, where the typical reported total is $5,209.

$620in general payments, 2019–2025

Across 19 payments — averaging $32.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$209
  • Medtronic$144
  • Cook Medical LLC$80
  • Kerecis Limited$51
  • W. L. Gore & Associates, Inc.$38
  • Conmed Corporation$34
  • plus $65 from 3 others
$12,651in research payments, 2019–2025

Across 8 payments — averaging $1581.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Humacyte Global, Inc.$13K

What the payments were for

  • Food & beverage$620100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$620 in reported general payments places this provider in the 15th percentile of 182 vascular surgery providers in New Jersey.

See all vascular surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$92,148
Medicare patients
219
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Pennington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →